MANE is trading 4.1% up today at $127.99 as traders continue to ride strong biotech momentum following recent positive clinical trial sentiment.
- The stock has maintained a powerful uptrend since late June, when Veradermics surged 13.21% on optimism surrounding its latest trial results.
- Investors are extending the bullish move higher despite a broadly mixed market backdrop.